Suzhou Highfine Biotech Co., Ltd.

301393

CNE1000064T6

Commodity Chemicals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-21 pm EDT			5-day change	1st Jan Change
47.95 ^CNY	+0.40%		-0.54%	-20.10%

Apr. 25	Suzhou Highfine Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 09	Suzhou Highfine Biotech Co., Ltd. Proposes Final Cash Dividend for the Year 2023	CI

Suzhou Highfine Biotech Co., Ltd. authorizes a Buyback Plan.

February 04, 2024

The Board of Directors of Suzhou Highfine Biotech Co., Ltd. has authorized a buyback plan on February 5, 2024.

Latest news about Suzhou Highfine Biotech Co., Ltd.

Suzhou Highfine Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Suzhou Highfine Biotech Co., Ltd. Proposes Final Cash Dividend for the Year 2023	Apr. 09	CI
Suzhou Highfine Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 08	CI
Tranche Update on Suzhou Highfine Biotech Co., Ltd.'s Equity Buyback Plan announced on February 5, 2024.	Apr. 01	CI
Suzhou Highfine Biotech Co., Ltd. announces an Equity Buyback for CNY 60 million worth of its shares.	Feb. 05	CI
Suzhou Highfine Biotech Co., Ltd. authorizes a Buyback Plan.	Feb. 04	CI
Suzhou Highfine Biotech Co., Ltd.(XSEC:301393) added to S&P Global BMI Index	Dec. 18	CI
Suzhou Highfine Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Kanghui Pharma Denies Speculations of Unit’s Involvement in Production of Weight-Loss Drugs	23-10-17	MT
Suzhou Highfine Biotech Co., Ltd. Announces Final Cash Dividend on A Shares for 2022, Payable on 21 September 2023	23-09-14	CI
Suzhou Highfine Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17	CI
Suzhou Highfine Biotech Co., Ltd. Approves Profit Distribution Proposal for 2022	23-08-14	CI
Suzhou Highfine Biotech Co., Ltd. Approves Election of Yu Jiahui as Independent Director	23-08-14	CI

Chart Suzhou Highfine Biotech Co., Ltd.

Duration

Period

More charts

Suzhou Highfine Biotech Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of Peptide synthesis reagents. The Company's main products include Peptide synthesis reagents such as condensation reagents, protection reagents and chiral racemic inhibition reagents, general-purpose molecular blocks and protein reagents.

Sector

Commodity Chemicals

Calendar

2024-08-15 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Suzhou Highfine Biotech Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

47.95

Average target price

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Commodity Chemicals

	1st Jan change	Capi.
SUZHOU HIGHFINE BIOTECH CO., LTD.	-20.10%	715M
AIR LIQUIDE	+4.00%	104B
SABIC	-7.31%	62.39B
PT CHANDRA ASRI PACIFIC TBK	+72.86%	48.95B
WANHUA CHEMICAL GROUP CO., LTD.	+18.82%	39.58B
LYONDELLBASELL INDUSTRIES N.V.	+3.62%	32.08B
WESTLAKE CORPORATION	+12.35%	20.22B
NINGXIA BAOFENG ENERGY GROUP CO., LTD.	+13.00%	16.86B
HENGLI PETROCHEMICAL CO.,LTD.	+16.25%	14.88B
RONGSHENG PETROCHEMICAL CO., LTD.	+2.22%	13.99B

Other Commodity Chemicals